Christopher Lyttle

Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients

Background— A Department of Veterans Affairs Cooperative Study randomized high-risk patients with medically refractory myocardial ischemia, a group largely excluded from previous trials, to urgent revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The present study examined the cost-effectiveness of PCI versus CABG for these high-risk patients. Methods and Results— Of 454 patients at 16 Department of Veterans Affairs medical centers, 445 were available for the economic analysis (218 PCI and 227 CABG patients). Total costs were assessed at 3 and 5 years from the third-party payer’s perspective, and effectiveness was measured by survival. After 3 years, average total costs were

Changing Impact of Gastroesophageal Reflux in Medical and Otolaryngology Practice

63 896 for PCI versus

Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: A nationwide claims-based investigation

84 364 for CABG patients, a difference of

Improving asthma self-efficacy: Developing and testing a pilot community-based asthma intervention for African American adults

20 468 (95% confidence interval [CI]

Environmental and state-level regulatory factors affect the incidence of autism and intellectual disability.

13 918 to

Asthma morbidity and treatment in the Chicago metropolitan area: one decade after national guidelines.

27 569). CIs were estimated by bootstrapping. Survival at 3 years was 0.82 for PCI versus 0.79 for CABG patients (P=0.34). Precision of the cost-effectiveness estimates were assessed by bootstrapping. PCI was less costly and more effective at 3 years in 92.6% of the bootstrap replications. After 5 years, average total costs were

The burden of asthma in the Chicago community fifteen years after the availability of national asthma guidelines: The design and initial results from the CHIRAH study☆

81 790 for PCI versus

Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma

100 522 for CABG patients, a difference of

Obesity and asthma morbidity in a community-based adult cohort in a large Urban area: The chicago initiative to raise asthma health equity (CHIRAH)

18 732 (95% CI

Original articleAsthma, lower airway diseaseAssociation of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma

9873 to